{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:47:05Z","timestamp":1791092825507,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T00:00:00Z","timestamp":1336608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2334-12-111","type":"journal-article","created":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T10:30:48Z","timestamp":1336645848000},"source":"Crossref","is-referenced-by-count":85,"title":["Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial"],"prefix":"10.1186","volume":"12","author":[{"given":"Rubhana","family":"Raqib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Protim","family":"Sarker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhirunnesa","family":"Mily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur Haque","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu Saleh Mohammed","family":"Arifuzzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rokeya Sultana","family":"Rekha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudmundur H","family":"Gudmundsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Cravioto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Agerberth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,5,10]]},"reference":[{"issue":"11","key":"1946_CR1","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.3201\/eid1611.090934","volume":"16","author":"P Bardhan","year":"2010","unstructured":"Bardhan P, Faruque AS, Naheed A, Sack DA: Decrease in shigellosis-related deaths withoutShigellaspp.-specific interventions, Asia. Emerg Infect Dis. 2010, 16 (11): 1718-1723. 10.3201\/eid1611.090934.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"1946_CR2","doi-asserted-by":"crossref","first-page":"G319","DOI":"10.1152\/ajpgi.2001.280.3.G319","volume":"280","author":"PJ Sansonetti","year":"2001","unstructured":"Sansonetti PJ: Microbes and microbial toxins: paradigms for microbial-mucosal interactions III. Shigellosis: from symptoms to molecular pathogenesis. Am J Physiol Gastrointest Liver Physiol. 2001, 280 (3): G319-G323.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"1946_CR3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1128\/IAI.63.1.289-296.1995","volume":"63","author":"R Raqib","year":"1995","unstructured":"Raqib R, Lindberg AA, Wretlind B, Bardhan PK, Andersson U, Andersson J: Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect Immun. 1995, 63 (1): 289-296.","journal-title":"Infect Immun"},{"issue":"5","key":"1946_CR4","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1128\/IAI.71.5.2684-2692.2003","volume":"71","author":"R Raqib","year":"2003","unstructured":"Raqib R, Moly PK, Sarker P, Qadri F, Alam NH, Mathan M, Andersson J: Persistence of mucosal mast cells and eosinophils in Shigella-infected children. Infect Immun. 2003, 71 (5): 2684-2692. 10.1128\/IAI.71.5.2684-2692.2003.","journal-title":"Infect Immun"},{"issue":"2","key":"1946_CR5","first-page":"133","volume":"43","author":"SK Niyogi","year":"2005","unstructured":"Niyogi SK: Shigellosis. J Microbiol. 2005, 43 (2): 133-143.","journal-title":"J Microbiol"},{"issue":"6870","key":"1946_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/415389a","volume":"415","author":"M Zasloff","year":"2002","unstructured":"Zasloff M: Antimicrobial peptides of multicellular organisms. Nature. 2002, 415 (6870): 389-395. 10.1038\/415389a.","journal-title":"Nature"},{"issue":"2","key":"1946_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/84627","volume":"7","author":"D Islam","year":"2001","unstructured":"Islam D, Bandholtz L, Nilsson J, Wigzell H, Christensson B, Agerberth B, Gudmundsson G: Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med. 2001, 7 (2): 180-185. 10.1038\/84627.","journal-title":"Nat Med"},{"issue":"5","key":"1946_CR8","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1084\/jem.20071698","volume":"205","author":"B Sperandio","year":"2008","unstructured":"Sperandio B, Regnault B, Guo J, Zhang Z, Stanley SL, Sansonetti PJ, Pedron T: Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression. J Exp Med. 2008, 205 (5): 1121-1132. 10.1084\/jem.20071698.","journal-title":"J Exp Med"},{"key":"1946_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3109\/00365529609094568","volume":"216","author":"PB Mortensen","year":"1996","unstructured":"Mortensen PB, Clausen MR: Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol Suppl. 1996, 216: 132-148.","journal-title":"Scand J Gastroenterol Suppl"},{"issue":"2","key":"1946_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1086\/314584","volume":"179","author":"GH Rabbani","year":"1999","unstructured":"Rabbani GH, Albert MJ, Hamidur Rahman AS, Moyenul Isalm M, Nasirul Islam KM, Alam K: Short-chain fatty acids improve clinical, pathologic, and microbiologic features of experimental shigellosis. J Infect Dis. 1999, 179 (2): 390-397. 10.1086\/314584.","journal-title":"J Infect Dis"},{"issue":"24","key":"1946_CR11","doi-asserted-by":"publisher","first-page":"9178","DOI":"10.1073\/pnas.0602888103","volume":"103","author":"R Raqib","year":"2006","unstructured":"Raqib R, Sarker P, Bergman P, Ara G, Lindh M, Sack DA, Nasirul Islam KM, Gudmundsson GH, Andersson J, Agerberth B: Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc Natl Acad Sci U S A. 2006, 103 (24): 9178-9183. 10.1073\/pnas.0602888103.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1946_CR12","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/INF.0b013e31819510b5","volume":"28","author":"GH Rabbani","year":"2009","unstructured":"Rabbani GH, Ahmed S, Hossain I, Islam R, Marni F, Akhtar M, Majid N: Green banana reduces clinical severity of childhood shigellosis: a double-blind, randomized, controlled clinical trial. Pediatr Infect Dis J. 2009, 28 (5): 420-425. 10.1097\/INF.0b013e31819510b5.","journal-title":"Pediatr Infect Dis J"},{"key":"1946_CR13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/bmb\/ldl001","volume":"75\u201376","author":"SL Jakobovits","year":"2005","unstructured":"Jakobovits SL, Travis SP: Management of acute severe colitis. Br Med Bull. 2005, 75\u201376: 131-144.","journal-title":"Br Med Bull"},{"issue":"5","key":"1946_CR14","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1699-0463.1994.tb04886.x","volume":"102","author":"R Raqib","year":"1994","unstructured":"Raqib R, Reinholt FP, Bardhan PK, Karnell A, Lindberg AA: Immunopathological patterns in the rectal mucosa of patients with shigellosis: expression of HLA-DR antigens and T-lymphocyte subsets. APMIS. 1994, 102 (5): 371-380.","journal-title":"APMIS"},{"issue":"8","key":"1946_CR15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1136\/ard.58.8.493","volume":"58","author":"G Cunnane","year":"1999","unstructured":"Cunnane G, Bjork L, Ulfgren AK, Lindblad S, FitzGerald O, Bresnihan B, Andersson U: Quantitative analysis of synovial membrane inflammation: a comparison between automated and conventional microscopic measurements. Ann Rheum Dis. 1999, 58 (8): 493-499. 10.1136\/ard.58.8.493.","journal-title":"Ann Rheum Dis"},{"issue":"5 Suppl","key":"1946_CR16","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1177\/014860719902300518","volume":"23","author":"A Andoh","year":"1999","unstructured":"Andoh A, Bamba T, Sasaki M: Physiological and anti-inflammatory roles of dietary fiber and butyrate in intestinal functions. JPEN J Parenter Enteral Nutr. 1999, 23 (5 Suppl): S70-S73. 10.1177\/014860719902300518.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"4","key":"1946_CR17","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1136\/gut.38.4.568","volume":"38","author":"JD Butzner","year":"1996","unstructured":"Butzner JD, Parmar R, Bell CJ, Dalal V: Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut. 1996, 38 (4): 568-573. 10.1136\/gut.38.4.568.","journal-title":"Gut"},{"issue":"964","key":"1946_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/pgmj.2005.037945","volume":"82","author":"M Song","year":"2006","unstructured":"Song M, Xia B, Li J: Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1\u03b2, and nuclear factor \u03baB in trinitrobenzene sulphonic acid induced colitis in rats. Postgrad Med J. 2006, 82 (964): 130-135. 10.1136\/pgmj.2005.037945.","journal-title":"Postgrad Med J"},{"issue":"12","key":"1946_CR19","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.3748\/wjg.v17.i12.1519","volume":"17","author":"RB Canani","year":"2011","unstructured":"Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A: Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol. 2011, 17 (12): 1519-1528. 10.3748\/wjg.v17.i12.1519.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1946_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1365-2036.2007.03562.x","volume":"27","author":"HM Hamer","year":"2008","unstructured":"Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ: Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008, 27 (2): 104-119.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1946_CR21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/infdis\/171.2.376","volume":"171","author":"R Raqib","year":"1995","unstructured":"Raqib R, Wretlind B, Andersson J, Lindberg AA: Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma. J Infect Dis. 1995, 171 (2): 376-384. 10.1093\/infdis\/171.2.376.","journal-title":"J Infect Dis"},{"issue":"1","key":"1946_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1046\/j.1365-2249.1999.01038.x","volume":"118","author":"A Andoh","year":"1999","unstructured":"Andoh A, Fujiyama Y, Hata K, Araki Y, Takaya H, Shimada M, Bamba T: Counter-regulatory effect of sodium butyrate on tumour necrosis factor-alpha (TNF-\u03b1)-induced complement C3 and factor B biosynthesis in human intestinal epithelial cells. Clin Exp Immunol. 1999, 118 (1): 23-29. 10.1046\/j.1365-2249.1999.01038.x.","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"1946_CR23","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S0016-5085(00)70142-9","volume":"118","author":"MS Inan","year":"2000","unstructured":"Inan MS, Rasoulpour RJ, Yin L, Hubbard AK, Rosenberg DW, Giardina C: The luminal short-chain fatty acid butyrate modulates NF-\u03baB activity in a human colonic epithelial cell line. Gastroenterology. 2000, 118 (4): 724-734. 10.1016\/S0016-5085(00)70142-9.","journal-title":"Gastroenterology"},{"issue":"3","key":"1946_CR24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.bcp.2005.04.030","volume":"70","author":"RF Place","year":"2005","unstructured":"Place RF, Noonan EJ, Giardina C: HDAC inhibition prevents NF-\u03baB activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I\u03baB\u03b1. Biochem Pharmacol. 2005, 70 (3): 394-406. 10.1016\/j.bcp.2005.04.030.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"1946_CR25","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1080\/003655202317316105","volume":"37","author":"H Luhrs","year":"2002","unstructured":"Luhrs H, Gerke T, Muller JG, Melcher R, Schauber J, Boxberge F, Scheppach W, Menzel T: Butyrate inhibits NF-\u03baB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol. 2002, 37 (4): 458-466. 10.1080\/003655202317316105.","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"1946_CR26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/gut.47.3.397","volume":"47","author":"JP Segain","year":"2000","unstructured":"Segain JP, Raingeard de la Bletiere D, Bourreille A, Leray V, Gervois N, Rosales C, Ferrier L, Bonnet C, Blottiere HM, Galmiche JP: Butyrate inhibits inflammatory responses through NF\u03baB inhibition: implications for Crohn's disease. Gut. 2000, 47 (3): 397-403. 10.1136\/gut.47.3.397.","journal-title":"Gut"},{"issue":"2","key":"1946_CR27","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0006-291X(02)00294-2","volume":"293","author":"M Kinoshita","year":"2002","unstructured":"Kinoshita M, Suzuki Y, Saito Y: Butyrate reduces colonic paracellular permeability by enhancing PPAR\u03b3 activation. Biochem Biophys Res Commun. 2002, 293 (2): 827-831. 10.1016\/S0006-291X(02)00294-2.","journal-title":"Biochem Biophys Res Commun"},{"issue":"15","key":"1946_CR28","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1016\/j.molimm.2007.04.010","volume":"44","author":"M Schwab","year":"2007","unstructured":"Schwab M, Reynders V, Loitsch S, Steinhilber D, Stein J, Schroder O: Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NF\u03baB signalling. Mol Immunol. 2007, 44 (15): 3625-3632. 10.1016\/j.molimm.2007.04.010.","journal-title":"Mol Immunol"},{"issue":"11","key":"1946_CR29","first-page":"855","volume":"1","author":"L Klampfer","year":"2003","unstructured":"Klampfer L, Huang J, Sasazuki T, Shirasawa S, Augenlicht L: Inhibition of interferon \u03b3 signaling by the short chain fatty acid butyrate. Mol Cancer Res. 2003, 1 (11): 855-862.","journal-title":"Mol Cancer Res"},{"issue":"7268","key":"1946_CR30","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/nature08530","volume":"461","author":"KM Maslowski","year":"2009","unstructured":"Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, et al: Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009, 461 (7268): 1282-1286. 10.1038\/nature08530.","journal-title":"Nature"},{"issue":"6","key":"1946_CR31","doi-asserted-by":"publisher","first-page":"e20637","DOI":"10.1371\/journal.pone.0020637","volume":"6","author":"P Sarker","year":"2011","unstructured":"Sarker P, Ahmed S, Tiash S, Rekha RS, Stromberg R, Andersson J, Bergman P, Gudmundsson GH, Agerberth B, Raqib R: Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia: a potential therapeutic strategy. PLoS One. 2011, 6 (6): e20637-10.1371\/journal.pone.0020637.","journal-title":"PLoS One"},{"issue":"5","key":"1946_CR32","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1023\/A:1005537411244","volume":"45","author":"P Vernia","year":"2000","unstructured":"Vernia P, Monteleone G, Grandinetti G, Villotti G, Di Giulio E, Frieri G, Marcheggiano A, Pallone F, Caprilli R, Torsoli A: Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis: randomized, double-blind, placebo-controlled pilot study. Dig Dis Sci. 2000, 45 (5): 976-981. 10.1023\/A:1005537411244.","journal-title":"Dig Dis Sci"},{"issue":"42","key":"1946_CR33","doi-asserted-by":"publisher","first-page":"18132","DOI":"10.1073\/pnas.1011737107","volume":"107","author":"P Veiga","year":"2010","unstructured":"Veiga P, Gallini CA, Beal C, Michaud M, Delaney ML, DuBois A, Khlebnikov A, van Hylckama Vlieg JE, Punit S, Glickman JN, et al: Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc Natl Acad Sci U S A. 2010, 107 (42): 18132-18137. 10.1073\/pnas.1011737107.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-111\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T11:26:29Z","timestamp":1594121189000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,10]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1946"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-111","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,10]]},"article-number":"111"}}